SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Duramed (DRMD) Synthetic Estrogen Product

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: JEB who wrote (1077)4/5/1999 8:29:00 PM
From: MoneyPenny  Read Replies (3) of 1837
 
unable to add scientific analysis here, I bought because I was studying ERT for myself and was attracted to this product. Over the weekend I noticed in my new print copy of Worth magazine, that they had included Cardinal Health in their list of the 50 best CEO's in the country to grow their businesses and Cardinal was one of the few health firms in the mix. This company's involvement will be good for DRMD. Don't think the article is on line yet but here is a short excerpt (typed with my less than stellar skills, I'm a cut and paste girl)

"Robert D. Walter, CEO of Cardinal Health since 1973, With last year's 5.4 billion acquisition of Allegiance, which distributes 300,000 products, Walter has positioned his $21 billion wholesale drug distributor as the leader of the pack in the rapidly consolidating medical-supply industry. <edit>an industry that has seen 150 major suppliers whittled down to just 45 over the past decade."

Anyway, he was 42 in a field of 50 CEO's rated for their vision, battle plans and personal style. Wouldn't make a decision based on the article but it does add confirmation to the DRMD selection of Cardinal for their product. Sharon
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext